정신간호학 약물

문서 내 토픽

1. Antipsychotic drugs(Typical Antipsychotics)

Haloperidol은 도파민 수용체를 차단함으로써 양성증상을 조절한다. 그러나 도파민 수용체 차단으로 인해 운동장애를 일으킬 수 있다. 정형 항정신병약물은 양성증상에 효과적이지만 음성증상에는 효과가 적다. 주요 부작용으로는 진정작용, 자율신경계 부작용, 추체외로계 증상, 지연성 운동장애, 신경이완제 악성증후군 등이 있다. 간호중재로는 부작용 모니터링, 불수의적 운동 측정, 부작용 관리 등이 필요하다.
2. Antipsychotic drugs(Atypical Antipsychotics)

Quetiapine은 도파민과 세로토닌 수용체를 동시에 차단하여 양성증상과 음성증상에 효과적이며 운동장애 부작용이 적다. 주요 부작용으로는 체중증가, 당뇨, 프로락틴 증가, 심전도 이상 등이 있다. 간호중재로는 감염 및 발열 증상 모니터링, 기립성 저혈압 관리, 약물 복용 관찰 등이 필요하다.
3. Antimanic drugs

Lithium carbonate는 기분안정제로 조증과 조울증 치료에 사용된다. 치료역이 좁아 독성 증상이 나타날 수 있으므로 주기적인 혈중농도 측정과 신체검진이 필요하다. 부작용으로는 기면, 어눌한 말씨, 근육약화, 오심, 구토, 설사 등이 있다. 간호중재로는 염분 섭취 관리, 수분 섭취 독려, 리튬 중독 시 적극적인 치료 등이 필요하다. Valproate는 GABA 작용을 강화하여 항조증 효과가 있으며, 주요 부작용으로는 위장관계 증상, 혈액학적 이상, 진전 등이 있다.
4. Antidepressant drugs

Escitalopram은 선택적 세로토닌 재흡수 억제제(SSRI)로 우울증 치료에 사용된다. 주요 부작용으로는 성기능 장애, 위장관계 증상, 중추신경계 증상 등이 있다. 간호중재로는 자살 위험 모니터링, 점진적 약물 감량, 부작용 관리 등이 필요하다. Trazodone은 세로토닌 길항제/재흡수 억제제로 진정효과와 항우울효과가 있으며, 주요 부작용으로는 중추신경계 증상, 지속발기증 등이 있다.
5. Antianxiety drugs

Lorazepam은 벤조디아제핀계 약물로 항불안, 진정, 근육이완 효과가 있다. 주요 부작용으로는 금단증상, 졸음, 어지러움, 우울 등이 있다. 간호중재로는 점진적 감량, 낙상 예방, 알코올 금지 등이 필요하다.
6. Anti-parkinsonic drugs

Levodopa는 파킨슨병 치료에 사용되며, 주요 부작용으로는 정신신경계 이상, 신경이완제 악성증후군, 소화기계 증상 등이 있다. 간호중재로는 점진적 용량 증가, 부작용 모니터링, 단백질 섭취 제한 등이 필요하다.

Easy AI와 토픽 톺아보기

1. Antipsychotic drugs(Typical Antipsychotics)

Typical antipsychotic drugs, also known as first-generation antipsychotics, are a class of medications primarily used to treat psychotic disorders such as schizophrenia. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a key role in the development of psychotic symptoms. While effective in reducing positive symptoms like hallucinations and delusions, typical antipsychotics can also cause significant side effects, including extrapyramidal symptoms (EPS) such as tremors, muscle stiffness, and involuntary movements. These side effects can be particularly problematic and may lead to poor medication adherence. Additionally, typical antipsychotics have been associated with an increased risk of tardive dyskinesia, a potentially irreversible movement disorder. Despite these drawbacks, typical antipsychotics remain an important treatment option, especially for patients who cannot tolerate or do not respond well to the newer, atypical antipsychotics. Careful monitoring and management of side effects are crucial when using these medications.
2. Antipsychotic drugs(Atypical Antipsychotics)

Atypical antipsychotics, also known as second-generation antipsychotics, are a newer class of medications that have been developed to address the limitations of typical antipsychotics. These drugs work by targeting a broader range of neurotransmitter systems, including serotonin and dopamine, which is believed to result in a more balanced and effective treatment approach. Compared to typical antipsychotics, atypical antipsychotics are generally associated with a lower risk of extrapyramidal symptoms and tardive dyskinesia. Additionally, they have been shown to be effective in treating both the positive and negative symptoms of schizophrenia, as well as improving cognitive function and overall quality of life for patients. However, atypical antipsychotics are not without their own set of potential side effects, which can include weight gain, metabolic changes, and an increased risk of cardiovascular problems. Careful monitoring and management of these side effects is essential to ensure the safe and effective use of atypical antipsychotics. Overall, the development of atypical antipsychotics has been a significant advancement in the treatment of psychotic disorders, offering a more well-rounded and potentially safer alternative to the older, typical antipsychotics.
3. Antimanic drugs

Antimanic drugs, also known as mood stabilizers, are a class of medications primarily used to treat bipolar disorder, a mental health condition characterized by episodes of mania and depression. These drugs work by stabilizing the mood and preventing the extreme mood swings associated with bipolar disorder. The most commonly used antimanic drugs include lithium, valproic acid, carbamazepine, and lamotrigine. Each of these medications has its own unique mechanism of action and set of potential side effects, and the choice of antimanic drug is often tailored to the individual patient's needs and response. Lithium, for example, is considered the gold standard for the treatment of bipolar disorder, as it has been shown to be effective in reducing the frequency and severity of manic and depressive episodes. However, lithium can also have significant side effects, such as tremors, weight gain, and thyroid and kidney problems, which require close monitoring. Valproic acid and carbamazepine are also commonly used antimanic drugs, with a slightly different side effect profile. Lamotrigine, on the other hand, is primarily used for the treatment of bipolar depression. Regardless of the specific antimanic drug chosen, the goal of treatment is to help patients achieve and maintain a stable mood, improve their overall functioning, and reduce the risk of relapse. Careful monitoring and management of side effects are crucial to ensure the safe and effective use of these medications.
4. Antidepressant drugs

Antidepressant drugs are a class of medications primarily used to treat depression, a mental health condition characterized by persistent feelings of sadness, hopelessness, and a loss of interest in daily activities. These drugs work by modulating the levels of certain neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine, which are believed to play a key role in the development of depression. The most commonly used antidepressant drugs include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). Each class of antidepressant has its own unique mechanism of action and set of potential side effects, and the choice of medication is often tailored to the individual patient's needs and response. SSRIs, such as fluoxetine (Prozac) and sertraline (Zoloft), are generally considered the first-line treatment for depression due to their relatively favorable side effect profile. SNRIs, such as venlafaxine (Effexor) and duloxetine (Cymbalta), are also commonly used and may be particularly effective for patients with comorbid chronic pain conditions. TCAs and MAOIs, on the other hand, are typically reserved for patients who have not responded to other antidepressant treatments, as they tend to have a higher risk of side effects. Regardless of the specific antidepressant chosen, the goal of treatment is to help patients achieve and maintain a stable mood, improve their overall functioning, and reduce the risk of relapse. Careful monitoring and management of side effects are crucial to ensure the safe and effective use of these medications.
5. Antianxiety drugs

Antianxiety drugs, also known as anxiolytics, are a class of medications primarily used to treat anxiety disorders, a group of mental health conditions characterized by persistent feelings of worry, fear, and apprehension. These drugs work by modulating the activity of certain neurotransmitters in the brain, such as gamma-aminobutyric acid (GABA), which is believed to play a key role in the regulation of anxiety. The most commonly used antianxiety drugs include benzodiazepines, such as diazepam (Valium) and alprazolam (Xanax), as well as non-benzodiazepine medications, such as buspirone (Buspar) and pregabalin (Lyrica). Benzodiazepines are generally considered the most effective and fast-acting antianxiety medications, but they also carry a higher risk of dependence and abuse. Non-benzodiazepine medications, on the other hand, are generally considered to have a lower risk of dependence, but they may be less effective in the short-term. Regardless of the specific antianxiety drug chosen, the goal of treatment is to help patients manage their anxiety symptoms, improve their overall functioning, and reduce the risk of relapse. Careful monitoring and management of side effects, as well as the potential for dependence, are crucial to ensure the safe and effective use of these medications.
6. Anti-parkinsonic drugs

Anti-parkinsonic drugs, also known as antiparkinsonian medications, are a class of medications primarily used to treat the symptoms of Parkinson's disease, a neurodegenerative disorder characterized by tremors, muscle stiffness, and impaired movement. These drugs work by modulating the levels of certain neurotransmitters in the brain, such as dopamine and acetylcholine, which are believed to play a key role in the development of Parkinson's disease symptoms. The most commonly used anti-parkinsonic drugs include levodopa, dopamine agonists, monoamine oxidase (MAO) inhibitors, and anticholinergic medications. Levodopa, which is converted to dopamine in the brain, is considered the gold standard for the treatment of Parkinson's disease, as it is highly effective in reducing motor symptoms. However, long-term use of levodopa can also lead to the development of motor complications, such as dyskinesia (involuntary movements). Dopamine agonists, such as pramipexole and ropinirole, are often used in combination with levodopa to help manage these motor complications. MAO inhibitors and anticholinergic medications, on the other hand, are typically used as adjunctive therapies to help manage specific symptoms, such as tremors and muscle rigidity. Regardless of the specific anti-parkinsonic drug chosen, the goal of treatment is to help patients manage their Parkinson's disease symptoms, improve their overall functioning, and slow the progression of the disease. Careful monitoring and management of side effects, as well as the potential for motor complications, are crucial to ensure the safe and effective use of these medications.

주제 연관 토픽을 확인해 보세요!

주제 연관 리포트도 확인해 보세요!